Bausch Health Companies (BHC) Receivables - Net (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Receivables - Net data on file, last reported at $2.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 5.74% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 5.74% YoY), and the FY2025 full-year result was $2.4 billion, up 9.86% from the prior year.
• Receivables - Net slipped to $2.2 billion in Q1 2026, from $2.4 billion in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $2.4 billion in Q3 2025 to a low of $144.0 million in Q4 2024.
• A 5-year average of $1.9 billion and a median of $2.0 billion in 2023 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net tumbled 92.79% in 2024 and surged 1532.64% in 2025, its largest moves.
• Tracing BHC's Receivables - Net over 5 years: stood at $1.8 billion in 2022, then rose by 11.62% to $2.0 billion in 2023, then plunged by 92.79% to $144.0 million in 2024, then surged by 1532.64% to $2.4 billion in 2025, then retreated by 6.81% to $2.2 billion in 2026.
• Business Quant data shows BHC's Receivables - Net at $2.2 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.